by
Medixo Centre 4 de março de 2024
Enzalutamide (XTANDI) has an unshakable position in the treatment of metastatic prostate cancer, and clinicians treating patients with advanced prostate cancer internationally are also very interested in enzalutamide. Familiar, becoming the standard of care for metastatic castration-resistant prosta...
